Tag Archives: Tim Lugo

Xenon (XENE) Gets a Buy Rating from William Blair

William Blair analyst Tim Lugo maintained a Buy rating on Xenon (XENE – Research Report) today. The company’s shares closed last Friday at $15.01. According to TipRanks.com, Lugo is a 5-star analyst with an average return of 10.6% and a

Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (NASDAQ: BMRN) and Dynavax (NASDAQ: DVAX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioMarin Pharmaceutical (BMRN – Research Report) and Dynavax (DVAX – Research Report) with bullish sentiments. BioMarin Pharmaceutical (BMRN) William Blair analyst Tim

William Blair Remains a Buy on Revance Therapeutics (RVNC)

In a report released today, Tim Lugo from William Blair maintained a Buy rating on Revance Therapeutics (RVNC – Research Report). The company’s shares closed last Monday at $15.27. According to TipRanks.com, Lugo is a 2-star analyst with an average

William Blair Maintains a Buy Rating on Allakos (ALLK)

William Blair analyst Tim Lugo maintained a Buy rating on Allakos (ALLK – Research Report) yesterday. The company’s shares closed last Monday at $50.89. According to TipRanks.com, Lugo is a 2-star analyst with an average return of -0.3% and a

Collegium Pharmaceutical (COLL) Gets a Buy Rating from William Blair

William Blair analyst Tim Lugo maintained a Buy rating on Collegium Pharmaceutical (COLL – Research Report) today. The company’s shares closed last Monday at $23.25, close to its 52-week high of $25.59. According to TipRanks.com, Lugo is a 4-star analyst

William Blair Sticks to Their Buy Rating for Collegium Pharmaceutical (COLL)

William Blair analyst Tim Lugo maintained a Buy rating on Collegium Pharmaceutical (COLL – Research Report) on January 8. The company’s shares closed last Monday at $23.54, close to its 52-week high of $23.75. According to TipRanks.com, Lugo is a